AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 176 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $739,000 | -3.7% | 48,874 | -42.0% | 0.02% | -11.1% |
| Q1 2022 | $767,000 | +111.9% | 84,335 | +63.4% | 0.02% | +200.0% |
| Q4 2021 | $362,000 | -54.3% | 51,599 | -25.7% | 0.01% | -53.8% |
| Q3 2021 | $792,000 | +16.6% | 69,491 | +82.9% | 0.01% | -7.1% |
| Q1 2021 | $679,000 | +207.2% | 37,989 | +153.6% | 0.01% | +27.3% |
| Q2 2020 | $221,000 | +52.4% | 14,977 | +39.1% | 0.01% | -15.4% |
| Q1 2020 | $145,000 | -75.7% | 10,767 | -65.3% | 0.01% | -35.0% |
| Q3 2019 | $597,000 | +20.6% | 31,049 | +85.4% | 0.02% | +42.9% |
| Q2 2019 | $495,000 | -7.5% | 16,744 | +52.1% | 0.01% | 0.0% |
| Q3 2017 | $535,000 | +6.6% | 11,010 | +15.2% | 0.01% | -6.7% |
| Q2 2017 | $502,000 | -21.7% | 9,561 | -43.7% | 0.02% | 0.0% |
| Q3 2016 | $641,000 | – | 16,990 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |